Kyowa Hakko Kirin’s first and only Rituxan (rituximab) biosimilar in Japan is showing a faster-than-expected uptake in the market, with the company racking up 4.3 billion yen from the cancer drug in 2018, far beyond its initial 3.2 billion yen…
HOME > BUSINESS
BUSINESS
- Novartis Files for Arbitration with ICC, Claiming No Obligation to Pay Certain Royalties for Fingolimod to Mitsubishi Tanabe
February 21, 2019
- Japan Pharma Market Down 1.7% in 2018, with Maviret as Top-Selling Product: IQVIA Data
February 21, 2019
- Janssen Files Protease Inhibitor/NRTIs Combo for HIV Infection in Japan
February 21, 2019
- Ono/Seikagaku’s Novel Osteoarthritis Drug Hits Primary Goal in Japan PIII
February 20, 2019
- EA Pharma Grabs Japan Rights to Dr. Falk’s Liver Therapy
February 20, 2019
- Suzuken, Toho to Set Up Generic JV, Share Systems in Specialty Pharma Business
February 20, 2019
- Shionogi, FunPep Link to Joint Research for Antibody-Inducing Peptides in Pain Field
February 19, 2019
- Taiyo Forms Capital Alliance with Regenerative Medicine Biotech
February 19, 2019
- As Japan Goes Digital on Package Inserts, Distributors Fret Proposed Paper-Based Rule on “1st Delivery”
February 18, 2019
- Crysvita Shows Long-Term Benefits in Pediatric XLH Study
February 18, 2019
- Shire’s Product Sales Up 3.9% in 2018: Takeda
February 18, 2019
- Asahi Kasei Pharma Sets Up New Firm for Teribone Authorized Generic
February 18, 2019
- Toa, Nipro, Nihon Generic Codeveloped Symbicort Copies, Launch Timing Unclear
February 18, 2019
- Merck Serono Japan to Be Renamed “Merck Biopharma” in April
February 18, 2019
- Rexulti Misses Primary Goal in Global PIII for Bipolar I Disorder: Otsuka, Lundbeck
February 18, 2019
- Ohara Licenses Novel Glioma Treatment from US Pharma Aiming to Bolster Pediatric Pipelines
February 18, 2019
- Mitsubishi Tanabe to Begin Clinical Study in US for c-Met Targeting ADC
February 15, 2019
- Ohara’s High-Need Pediatric Cancer Drug in Limbo 2 Years after Approval due to GMP Issue
February 15, 2019
- Kowa to Reshuffle Pharma Business in April, Launching New Company for LLP Operations
February 15, 2019
- Armed with Positive Data, G47Δ Could Reach Filing in May as Japan’s 1st Oncolytic Virus
February 14, 2019
ページ
Members of a key reimbursement policy panel appear to be becoming more and more open to the industry’s call for…
A series of drug makers restructured or sold off production facilities in FY2018. Others dissolved or withdrew from the pharmaceutical business altogether. The entry of generics and transfer of products triggered these moves, but the underlying factor was the impact…
With a cursory glance, recruitment is easily defined. We’re here to help place candidates into the vacancies our clients need to fill. Armed with a pen and paper, you could even map out the process.• We study the market• We…